Articles about Product Safety

...

Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate New Drug Application Resubmission and PDUFA Date of March 25, 2027

Today 15:05 EDT

Via B2i Digital

Playroom Architect Addresses Water Beads Hidden in Squishy Toys Following Recent Recalls, Offers Sensory Play Safety Guidance

Today 12:45 EDT

Via Press Advantage

HER2-Positive Gastric Cancer Market Forecast to Reach US$2.05 Billion by 2035 as First-Line Treatment Options Expand | Report by DataM Intelligence

Today 10:32 EDT

Via Press Release Distribution Service

NeOnc's Brain Cancer Efforts Bring Hope as FDA Meeting Approaches

Today 10:17 EDT

Via Newsfile

AbbVie vs. Bristol Myers Squibb: Faster Growth or Steady Revenue? ↗

Today 9:20 EDT

Via The Motley Fool

BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Completes Enrollment Ahead of Schedule in 486-Patient Heart Attack Detection Study

Today 9:04 EDT

Via Investor Brand Network

What Are the Chinese Paper Tube Suppliers? A Buyer's Guide to Sourcing from China's Paper Packaging Hub

Today 3:55 EDT

Via Press Release Distribution Service

NetworkNewsBreaks – SS Innovations International Inc. (NASDAQ: SSII) Unveils SSi Mantra 3.0 at Kings Hospital Colombo

October 20, 2026

Via Investor Brand Network

Why Baxter (BAX) Stock Is Down Today

October 20, 2026

Via StockStory

Ocular Therapeutix Eyes Q4 FDA Filing for AXPAXLI After SOL-1 Win ↗

October 20, 2026

Via MarketBeat

DSCP Smart Fulfillment Launches Cosmetics and Beauty Fulfillment for International Brands Entering the US Market

October 20, 2026

Via Press Advantage

Kaplan Fox Encourages Beta Bionics, Inc. (NASDAQ: BBNX) Investors Seeking Recovery to Contact the Firm Before November 3, 2026

October 20, 2026

Via NewMediaWire

Envoy Medical Hits Six-Month Milestone, Marks Halfway Point in Final Stage of Data Collection, and Highlights Differentiated Device Design

October 20, 2026

Via Newsfile

GoingClear's LAB Medical Website Redesign Named a DesignRush Awards Finalist

October 20, 2026

Via Newsfile

MEDDDICAL Announces AI-Driven RWE Analytics For MedTech & Pharma Organisations

October 20, 2026

Via Press Release Distribution Service

CytoDyn Highlights Early CLOVER Data, Names Robert Hoffman CEO ↗

October 19, 2026

Via MarketBeat

Final Step Completed for FDA Process Validation; Two-Year Stability for Preservative-Free Ketamine Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)

October 19, 2026

Via Get News

Why Natera (NTRA) Stock Is Up Today

October 19, 2026

Via StockStory

Commercial Manufacturing Validation Completed as November 10 FDA Milestone Approaches; Critical FDA Milestone Close: NRx Pharmaceuticals NAS DAQ: NRXP

October 19, 2026

Via PRLog

Disc Medicine’s Bitopertin Nails Phase III Endpoints, Eyes FDA Resubmission ↗

October 19, 2026

Via MarketBeat

When Lake Naivasha’s water dropped, its fish eagles started hunting from the backs of hippos

October 19, 2026

Via AB Newswire

Gilead Sciences Is on an FDA Approval Hot Streak. Should You Buy the Stock Like There's No Tomorrow? ↗

October 18, 2026

Via The Motley Fool

Moderna Just Joined the Nasdaq-100. Here's What That Means for Investors. ↗

October 18, 2026

Via The Motley Fool

IntelliXR Launches Its Platform for Eye and Brain Biomarkers

October 17, 2026

Via Press Release Distribution Service

The Nasdaq-100's 6 Best Stocks This Year, and Whether They Can Keep Going ↗

October 17, 2026

Via The Motley Fool

Kaplan Fox Alerts Beta Bionics, Inc. (NASDAQ: BBNX) Investors to a Securities Fraud Lawsuit - Lead Plaintiff Deadline is November 3, 2026

October 16, 2026

Via NewMediaWire

DataMeds Applauds FDA’s Proposed Interim Access Policy for Compounding Using Certain Peptides and Provides Corexa Health’s Peptides Roadmap

October 16, 2026

Via B2i Digital

Adagene Highlights SAFEbody Pipeline, ADG138 Clinical Launch and 2027 Catalysts ↗

October 16, 2026

Via MarketBeat

Guy Gentile Announces The Short Seller, a New Book on the Mechanics and Risks of Short Selling

October 16, 2026

Via Newsfile

Kaplan Fox Alerts Investors to an Upcoming Deadline of November 2, 2026 in the Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Securities Class Action

October 16, 2026

Via NewMediaWire

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.